Report cover image

North America Veterinary Clinical Trials Market Size, Share, Trends, Industry Analysis Report: Information By Animal Type (Livestock Animal, Companion Animal, Other Animals), By Intervention, By Indication, By End User, and By Country (U.S. And Canada) –

Publisher Polaris Market Research & Consulting LLP
Published Aug 01, 2024
Length 117 Pages
SKU # PLRS19140070

Description

North America Veterinary Clinical Trials Market Size, Share, Trends, Industry Analysis Report: Information By Animal Type (Livestock Animal, Companion Animal, Other Animals), By Intervention, By Indication, By End User, and By Country (U.S. And Canada) – Market Forecast, 2024 - 2032



The North America veterinary clinical trials market size is expected to reach USD 3,841.20 million by 2032, according to a new study by Polaris Market Research. The report “North America Veterinary Clinical Trials Market Size, Share, Trends, Industry Analysis Report, By Animal Type (Livestock Animal, Companion Animal, Other Animals); By Intervention; By Indication; By End Use; By Country; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The development of new drugs, vaccines, and biologics requires rigorous clinical trials to ensure safety and efficacy. Personalized treatments based on genetic profiling of animals boost the need for specialized clinical trials and drive the demand for the North America veterinary clinical trials market.

Also, increasing pet ownership and the humanization of pets have led to higher spending on veterinary healthcare, necessitating advanced treatments and clinical trials. Technological innovations, such as digital health tools and advanced diagnostic imaging, enhance the scope and efficiency of trials.

Regulatory support from bodies like the FDA and Health Canada, coupled with stringent animal welfare regulations, fosters a conducive environment for conducting clinical trials. Collaboration between pharmaceutical companies, research institutions, and veterinary clinics, along with public-private partnerships, accelerates research and development.

The growing prevalence of chronic and infectious diseases in animals drives the need for effective treatments and vaccines. Increased healthcare expenditure and significant investments in veterinary research further bolster the veterinary clinical trials market.

Furthermore, enhanced education and training programs for veterinarians improve the implementation and management of clinical trials. Additionally, growing awareness among pet owners about advanced veterinary care and the economic impact of maintaining livestock health contribute to the demand for veterinary clinical trials market.

North America Veterinary Clinical Trials Market Report Highlights
  • In 2023, the companion animal segment accounted for the largest market share due to a rise in pet ownership, driven by changing lifestyles, urbanization, and increased disposable income.
  • The pharmaceutical and biopharmaceutical companies segment accounted for the largest market share in 2023 due to their heavy investment in research and development to create innovative veterinary drugs, vaccines, and therapies.
  • The U.S. veterinary clinical trials market accounted for the largest market share in 2023 due to its highly developed regulatory framework, particularly through the FDA (Food and Drug Administration), which sets stringent standards for the approval of veterinary products.
  • The Nort America key market players include Argenta, Boehringer Ingelheim International GmbH., Charles River Laboratory, Clinvet, Cambridge Technologies, Knoell, IDEXX Laboratories, Inc., Labcorp Drug Development, Merck & Co., Inc., and Vivesto AB.
Polaris Market Research has segmented the North America veterinary clinical trials market report based on animal type, intervention, indication, end-user, and country:

Veterinary Clinical Trials, Animal Type Outlook (Revenue - USD Million, 2019 - 2032)
  • Livestock Animal
  • Companion Animal
  • Other Animals
Veterinary Clinical Trials, Intervention Outlook (Revenue - USD Million, 2019 - 2032)
  • Medicines
  • Medical Device
  • Others
Veterinary Clinical Trials, Indication Outlook (Revenue - USD Million, 2019 - 2032)
  • Orthopedics
  • Oncology
  • Cardiology
  • Ophthalmology
  • Neurology
  • Dermatology
  • Internal Medicine
  • Other Indication
Veterinary Clinical Trials, End-User Outlook (Revenue - USD Million, 2019 - 2032)
  • Academics And Research Centers
  • Pharmaceutical And Biopharmaceutical Companies
  • Others
Veterinary Clinical Trials, Country Outlook (Revenue - USD Million, 2019 - 2032)
  • North America
  • US
  • Canada

Table of Contents

117 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. North America Veterinary Clinical Trials Market Insights
4.1. Veterinary Clinical Trials Market – Application Snapshot
4.2. Veterinary Clinical Trials Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rise in Technological Advancements Driving the Market Growth
4.2.1.2. Increasing Regulatory Support and Framework
4.2.2. Restraints and Challenges
4.2.2.1. Regulatory Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Veterinary Clinical Trials Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. North America Veterinary Clinical Trials Market, by Animal Type
5.1. Key Findings
5.2. Introduction
5.2.1. North America Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD Million)
5.3. Companion Animal
5.3.1. North America Veterinary Clinical Trials Market, by Companion Animal, by Country, 2019-2032 (USD Million)
5.4. Livestock Animal
5.4.1. North America Veterinary Clinical Trials Market, by Livestock Animal, by Country, 2019-2032 (USD Million)
5.5. Other Animals
5.5.1. North America Veterinary Clinical Trials Market, by Others Animal, by Country, 2019-2032 (USD Million)
6. North America Veterinary Clinical Trials Market, by Intervention
6.1. Key Findings
6.2. Introduction
6.2.1. North America Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
6.3. Medicines
6.3.1. North America Veterinary Clinical Trials Market, by Medicines, by Country, 2019-2032 (USD million)
6.4. Medical Device
6.4.1. North America Veterinary Clinical Trials Market, by Medical Device, by Country, 2019-2032 (USD million)
6.5. Others
6.5.1. North America Veterinary Clinical Trials Market, by Others, by Country, 2019-2032 (USD million)
7. North America Veterinary Clinical Trials Market, by Indication
7.1. Key Findings
7.2. Introduction
7.2.1. North America Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
7.3. Orthopedics
7.3.1. North America Veterinary Clinical Trials Market, by Orthopedics, By Country, 2019-2032 (USD million)
7.4. Oncology
7.4.1. North America Veterinary Clinical Trials Market, by Oncology, By Country, 2019-2032 (USD million)
7.5. Cardiology
7.5.1. North America Veterinary Clinical Trials Market, by Cardiology, By Country, 2019-2032 (USD million)
7.6. Ophthalmology
7.6.1. North America Veterinary Clinical Trials Market, by Ophthalmology, By Country, 2019-2032 (USD million)
7.7. Neurology
7.7.1. North America Veterinary Clinical Trials Market, by Neurology, By Country, 2019-2032 (USD million)
7.8. Dermatology
7.8.1. North America Veterinary Clinical Trials Market, by Dermatology, By Country, 2019-2032 (USD million)
7.9. Internal Medicine
7.9.1. North America Veterinary Clinical Trials Market, by Internal Medicine, By Country, 2019-2032 (USD million)
7.10. Other Indication
7.10.1. North America Veterinary Clinical Trials Market, by Other Indication, By Country, 2019-2032 (USD million)
8. North America Veterinary Clinical Trials Market, by End User
8.1. Key Findings
8.2. Introduction
8.2.1. North America Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
8.3. Academics And Research Centers
8.3.1. North America Veterinary Clinical Trials Market, by Academics and Research Centers, By Country, 2019-2032 (USD million)
8.4. Pharmaceutical And Biopharmaceutical Companies
8.4.1. North America Veterinary Clinical Trials Market, by Pharmaceutical and Biopharmaceutical Companies, By Country, 2019-2032 (USD million)
8.5. Others
8.5.1. North America Veterinary Clinical Trials Market, by Others, By Country, 2019-2032 (USD million)
9. North America Veterinary Clinical Trials Market, by Country
9.1. Key findings
9.2. Introduction
9.2.1. Veterinary Clinical Trials Market Assessment, By Country, 2019-2032 (USD million)
9.3. Veterinary Clinical Trials Market – North America
9.3.1. North America: Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD million)
9.3.2. North America: Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
9.3.3. North America: Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
9.3.4. North America: Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
9.3.5. North America Veterinary Clinical Trials Market – U.S.
9.3.5.1. U.S.: Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD million)
9.3.5.2. U.S.: Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
9.3.5.3. U.S.: Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
9.3.5.4. U.S.: Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
9.3.6. North America Veterinary Clinical Trials Market – Canada
9.3.6.1. Canada: Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD million)
9.3.6.2. Canada.: Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
9.3.6.3. Canada: Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
9.3.6.4. Canada: Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Argenta
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Boehringer Ingelheim International GmbH
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Cambridge Technologies
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Charles River Laboratory
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Clinvet
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. IDEXX Laboratories, Inc.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Knoell
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. Labcorp Drug Development
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Merck & Co., Inc.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. Vivesto AB
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us